| Literature DB >> 31450869 |
Anca Onaciu1, Raluca Andrada Munteanu1, Alin Iulian Moldovan1,2, Cristian Silviu Moldovan1,2,3, Ioana Berindan-Neagoe4,5,6.
Abstract
Hydrogels represent 3D polymeric networks specially designed for various medical applications. Due to their porous structure, they are able to swollen and to entrap large amounts of therapeutic agents and other molecules. In addition, their biocompatibility and biodegradability properties, together with a controlled release profile, make hydrogels a potential drug delivery system. In vivo studies have demonstrated their effectiveness as curing platforms for various diseases and affections. In addition, the results of the clinical trials are very encouraging and promising for the use of hydrogels as future target therapy strategies.Entities:
Keywords: biocompatibility; drug delivery; hydrogels; in vivo administration; polymers; target therapy
Year: 2019 PMID: 31450869 PMCID: PMC6781314 DOI: 10.3390/pharmaceutics11090432
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Hydrogel medical applications.
Figure 2Stimuli sensitive hydrogels structural changes. (A) Stimuli categories: physical, biological and chemical. (B) Physical hydrogels are non-covalently crosslinked and in an aqueous environment, they swell. Under various stimuli presence, they undergo reversible structure modifications and release the compound. (C) Chemical hydrogels describes covalently crosslinked formulation that swells in aqueous conditions and then suffers reversible or irreversible alterations depending on stimuli presence and crosslinking strength, which influence their discharge.
Hydrogel classification according various parameters, their properties and corresponding applications.
| Parameter | Hydrogel Type | Hydrogel Composition | Properties | Applications |
|---|---|---|---|---|
| Chemical stimuli | pH responsive | Carboxylated agarose/tannic acid hydrogel scaffolds cross-linked with zinc ions [ | Sustained release of the incorporated drugs [ | Drug delivery [ |
| Ionic strength responsive | 2-acrylamido-2-methylpropane sulfonic acid crosslinked with | Increased swelling properties [ | Depollution of aqueous ecosystems [ | |
| Solvent composition responsive | Fluorenylmethoxycarbonyl diphenylalanine [ | Uniform networks [ | Sensing [ | |
| Molecules responsive | Achieves molecular recognition, High affinity and specificity [ | Sensing [ | ||
| Physical stimuli | Temperature responsive | Two categories: low critical solution temperature [ | Tissue engineering [ | |
| Electric field responsive | Polypyrrole polymeric nanoparticles loaded in poly lactic- | Controlled release of the cargo [ | Drug delivery [ | |
| Magnetic field responsive | Hemicellulose crosslinked with O-acetyl-galactoglucomannan [ | Successful absorption and controlled release of drugs [ | Tissue engineering [ | |
| Light responsive | Hydroxypropyl methylcellulose and Carbopol hydrogels containing diclofenac-sodium chitosan microspheres [ | Reasonable strengthens according to application [ | Drug delivery [ | |
| Pressure responsive | Polyacrylamide and poly(acrylamide-hydroxyethyl methacrylate) [ | Thermo- and pH sensitive [ | Sensing [ | |
| Polymer origin | Natural | Nanofibrillar cellulose [ | Biomimetic and adhesion capacity [ | Tissue engineering [ |
| Synthetic | Low acyl gellan gum bilayered hydrogel scaffolds [ | Controllable structure and other physico-chemical properties [ | Drug delivery [ | |
| Hybrid | Alginate-polymethacrylate [ | Biomimetic capacity [ | Tissue engineering, drug delivery [ | |
| Biodegradability | Biodegradable | Chitosan-gelatin [ | Stable and biocompatible [ | Drug delivery [ |
| Non-biodegradable | Poly(2-hydroxyethyl methacrylate) [ | Biocompatibility [ | Tissue engineering [ |
Figure 3In vivo drug delivery hydrogel routes of administration. There are various methods for in vivo administration of hydrogel based products depending on the pathological conditions and their localization. Subcutaneous injection plays a crucial role in toxicological effects evaluation. Topical or transdermal application is preferred for skin associated problems. Orthotopic and intraperitoneal injections are non-invasive techniques which ensure good therapy results. On the other hand, oral administration has some limitations because of digestive enzymes.
Different completed clinical trials using hydrogel based products (ClinicalTrials.gov).
| Condition | Product | Benefits | Reference |
|---|---|---|---|
| Prostate cancer radiotherapy | Hydrogel spacer | Minimal side effects and toxicity | [ |
| Gynecologic laparoscopic surgery | Crosslinked hyaluronan gel | Safety use | [ |
| Corneal epithelial permeability | Silicone hydrogel contact lenses | Improves epithelial permeability when used with ophthalmic solutions | [ |
| Corneal infiltrates | Identification of bacterial species during continuous wear of contact lenses | [ | |
| Myopia | Good ocular comfort | [ | |
| Dry eye syndrome | Crosslinked hyaluronic acid with liposomes and crocin | Safety profile | [ |
| Urinary incontinence | Polyacrylamide hydrogel | Facilitates urinary incontinence symptoms for patients that are ineligible for midurethral sling surgery | [ |
| Cerebrospinal fluid leak | Fibrin sealant | Efficient adjunct to dural sutures repair | [ |
| Diabetes, foot ulcer | Hydrogel/hydrocolloid | Promotes wound healing | [ |
| Intracranial aneurysm | Hydrogel coils | Efficient endovascular coil embolization | [ |
| Cerebral aneurysm | Improves aneurysm packing | [ | |
| Submucosal tumor of gastrointestinal tract | Calcium-alginate gel | No adverse events and no tissue injuries | [ |
| Oral mucositis | Mucoadhesive hydrogel | Safety profile and tolerability | [ |
| Myoma | Resorbable hydrogel | Safety and efficacy | [ |
| Pulmonary emphysema | Fibrin hydrogel | Safe profile and no major adverse effects | [ |
| Lung cancer biopsy | Hydrogel plug | Reduces postbiopsy pneumothorax and other complications associated with CT guided coaxial needle biopsy | [ |
| Ischemic cardiomyopathy | Gelatin hydrogel | Controlled release of fibroblast growth factor | [ |
| Heart failure | Alginate hydrogel | Efficiency and safety profile | [ |
| Elective cranial procedures with dural incision | PEG hydrogel | Safe profile | [ |
| Neuropathic pain | Lidocaine plaster | Safety and tolerability profile | [ |